blood cancer
Harnessing the Potential of CAR T-Cell Therapy for Multiple Myeloma
Multiple myeloma, a blood cancer that develops in plasma cells, can result in low blood counts and weakening of the ...
FEBRUARY 3, 2025
FDA Approves First Treatment for Erdheim-Chester Disease
The first FDA-approved treatment for ECD, Zelboraf is indicated to treat patients whose cancer cells have ...
NOVEMBER 7, 2017
Load more